Thankful to @greenjrnl in helping me realize a life long dream! This has been a labour of love for the benefit of pregnant people with SCD.
Association of Sickle Cell Disease With Severe Maternal Morb... : Obstetrics & Gynecology https://t.co/3QXWamFErQ
Ugandan children with sickle cell anemia who received 10 years of hydroxyurea therapy had sustained laboratory and clinical benefits, improved growth, and few toxic effects. Read the full summary of research findings: https://t.co/tHMY8RTskL
Presented at #ASCO26:
In high-risk localized prostate cancer, ADT plus apalutamide led to a pathological complete response or minimal residual disease and 5-year metastasis-free survival in a greater percentage of patients than ADT plus placebo. Full phase 3 PROTEUS trial results: https://t.co/UxXUkYwd8Z
Editorial: A Watershed Moment in the Perioperative Treatment of Prostate Cancer https://t.co/XgeWL3lqy6
@ASCO
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq
@ASCO
A historic moment at #ASCO26: more than 9,000 oncologists rose for three standing ovations as Brian Wolpin, MD, MPH, Director of the Hale Family Center for Pancreatic Cancer Research, presented promising new Phase 3 results for an investigational treatment for metastatic pancreatic cancer.
In the trial, daraxonrasib helped patients with previously treated metastatic pancreatic cancer live significantly longer than those who received chemotherapy.
While more work remains, these findings offer something powerful: hope for patients and families facing one of the most challenging cancers.
As Dr. Wolpin said, “It is exciting to see that we may soon be able to help patients with metastatic pancreatic cancer in ways we haven’t been able to before, improving both survival and quality of life.”
Congratulations to the researchers and patients who made this important progress possible. 👏👏👏
Video Courtesy: @asco
We choose to go to the moon: not because it is easy, but because it is hard. Because that goal will serve to measure the best of our energies & skills, because that challenge is one that we are willing to accept, one we are unwilling to postpone, & one which we intend to win.
To commemorate the Artemis II mission, the astronauts announced their suggestion to rename certain features on the Moon to honor the Orion spacecraft, named Integrity, as well as commander Reid Wiseman's late wife, Carroll.
Hello, Moon. It’s great to be back.
Here’s a taste of what the Artemis II astronauts photographed during their flight around the Moon. Check out more photos from the mission: https://t.co/rzM1P0QbOl
In this retrospective cohort study from Norway and Taiwan, paternal use of valproate within 90 days before conception was not associated with an increased risk of neurodevelopmental disorders in offspring after adjustment for confounding. Full results: https://t.co/6jyk6Bzl6l
📊 Research Summary: Among patients with multiorgan metastatic #ColorectalCancer, tumor debulking combined with systemic chemotherapy failed to provide a survival benefit over chemotherapy alone and resulted in higher rates of serious adverse events.
https://t.co/L93KGJeeZq
Group B streptococcal infection mostly affects newborns, infants, pregnant persons, and older adults. Perinatal prevention is successful but contributes to antibiotic exposure. Multivalent glycoconjugate vaccines are in development. Read the full review: https://nej.md/4aJJ6Pv
Prenatal exposure to acid-suppressive medication, including proton pump inhibitors and histamine 2 receptor antagonists, was not associated with increased risk of #ADHD, #ASD, or other neuropsychiatric disorders in children.
https://t.co/9Nty4kR0sn
Higher intake of caffeinated coffee or tea was associated with a lower risk of #dementia and modestly improved #cognitive function, with maximal benefit seen at moderate consumption levels.
🎥 Watch the video and read the full study: https://t.co/QzaKlAjLZh
A new gen-AI model, called DNA-Diffusion, creates short DNA sequences capable of turning genes on or off in specific cells. The researchers hope that the technology could one day be part of gene therapies to treat disease. https://t.co/8w4SDjG1RM
It was a rainy, yet cozy 2026! We explored the beauty of the outdoors and saw a few unexpected rainbows 🌈. Wishing you all a happy and healthy new year!